Diana Peng Bockus

Chief Executive Officer at NGM Bio.

Earliest Form D on file: Mar 2026

Filed Mar 27, 2026Amendment

NGM Bio

Antibody drugs for pregnancy nausea and cancer wasting

Biotech, South San Francisco CA

Signed as Chief Executive Officer

$142M

sold of $142M offered

Reported on an amendment to an earlier filing.

Network

At NGM Bio

3 people